Woodline Partners’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Sell |
85,177
-74,909
| -47% | -$1.2M | 0.01% | 773 |
|
|
2025
Q1 | $2.43M | Sell |
160,086
-1,635
| -1% | -$24.9K | 0.02% | 637 |
|
|
2024
Q4 | $3.28M | Buy |
161,721
+2,567
| +2% | +$52.1K | 0.02% | 569 |
|
|
2024
Q3 | $4.09M | Buy |
159,154
+1,207
| +0.8% | +$31K | 0.03% | 408 |
|
|
2024
Q2 | $2.03M | Buy |
157,947
+588
| +0.4% | +$7.56K | 0.02% | 410 |
|
|
2024
Q1 | $3.6M | Buy |
+157,359
| New | +$3.6M | 0.03% | 390 |
|
|
2022
Q3 | – | Sell |
-20,606
| Closed | -$929K | – | 819 |
|
|
2022
Q2 | $929K | Hold |
20,606
| – | – | 0.01% | 524 |
|
|
2022
Q1 | $2.03M | Hold |
20,606
| – | – | 0.03% | 374 |
|
|
2021
Q4 | $3.15M | Hold |
20,606
| – | – | 0.05% | 350 |
|
|
2021
Q3 | $2.79M | Sell |
20,606
-10
| -0% | -$1.36K | 0.05% | 356 |
|
|
2021
Q2 | $3.03M | Buy |
+20,616
| New | +$3.03M | 0.06% | 292 |
|